$1.54 Billion is the total value of TYBOURNE CAPITAL MANAGEMENT (HK) LTD's 9 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KMI | Exit | KINDER MORGAN INC | $0 | – | -7,831,263 | -100.0% | -9.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AMAZON.COM INC (AMZN US) | 45 | Q2 2024 | 22.4% |
MERCADOLIBRE INC (MELI US) | 21 | Q2 2024 | 15.1% |
BICYCLE THERAPEUTICS PLC | 21 | Q2 2024 | 6.6% |
SALESFORCE COM INC | 19 | Q1 2020 | 28.5% |
VISA INC-CLASS A SHARES (V US) | 18 | Q1 2024 | 9.1% |
SQUARE INC - A (SQ US) | 18 | Q2 2024 | 6.3% |
NETFLIX INC | 17 | Q2 2020 | 20.6% |
ATLASSIAN CORP PLC-CLASS A (TEAM US) | 17 | Q2 2022 | 13.9% |
SEA LTD-ADR (SE US) | 17 | Q2 2024 | 9.8% |
ZENTALIS PHARMACEUTICALS INC (ZNTL US) | 17 | Q2 2024 | 6.6% |
View TYBOURNE CAPITAL MANAGEMENT (HK) LTD's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Forte Biosciences, Inc. | February 14, 2024 | 3,630,468 | 10.0% |
Zentalis Pharmaceuticals, Inc. | February 14, 2023 | 2,231,427 | 3.9% |
EXICURE, INC. | May 11, 2022 | 5,856,310 | 4.8% |
BICYCLE THERAPEUTICS plc | March 14, 2022 | 1,408,259 | 4.8% |
TPG Pace Beneficial Finance Corp.Sold out | January 03, 2022 | 0 | 0.0% |
Farfetch Ltd | February 16, 2021 | 5,354,942 | 1.8% |
BOSTON BEER CO INCSold out | February 14, 2018 | 0 | 0.0% |
Workday, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
DUNKIN' BRANDS GROUP, INC.Sold out | February 14, 2017 | 0 | 0.0% |
On Deck Capital, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
View TYBOURNE CAPITAL MANAGEMENT (HK) LTD's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-19 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-02-14 |
13F-HR | 2023-02-14 |
View TYBOURNE CAPITAL MANAGEMENT (HK) LTD's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.